Limited role in the workup of myeloproliferative neoplasms in the setting of an otherwise optimal cytogenetic study. Aids in exclusion of cryptic BCR-ABL1 rearrangement in chronic myelogenous leukemia and in the exclusion of a PDGFRA abnormality in cases of neoplastic eosinophilia.
Fluorescence in situ Hybridization (FISH)
New York DOH Approval Status
Non-diluted bone marrow collected in a heparinized syringe. Also acceptable: Green (sodium heparin).
Transfer 3 mL bone marrow to a green (sodium heparin) (Min: 1 mL). OR transport 5 mL whole blood (Min: 2 mL).
Frozen specimens. Paraffin-embedded specimens. Clotted specimens.
Ambient: 48 hours; Refrigerated: 48 hours; Frozen: Unacceptable
Probes included: BCR/ABL, PDGFR-alpha, PDGFR-beta, and, FGFR1.
This test was developed and its performance characteristics determined by ARUP Laboratories. It has not been cleared or approved by the US Food and Drug Administration. This test was performed in a CLIA certified laboratory and is intended for clinical purposes.
Analyte Specific Reagent (ASR)
A processing fee will be charged if this procedure is canceled, at the client's request, after the test has been set up, or if the specimen integrity is inadequate to allow culture growth. The fee will vary based on specimen type.
Other specimen types may be acceptable, contact the Cytogenetics Laboratory for specific specimen collection and transportation instructions.
If cell pellets or dropped cytogenetics slides are not submitted, a processing fee will apply.
This test must be ordered using Oncology test request form #43099 or through your ARUP interface.
88271 x4; 88275 x4
|Component Test Code*||Component Chart Name||LOINC|
|2002361||MPD Panel by FISH|
|2002362||EER FISH MPD P|